STOCK TITAN

Ardelyx to Participate at the Cowen 44th Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Ardelyx, Inc. announced that Susan Rodriguez, chief commercial officer, will participate in a Cardiorenal panel discussion at the Cowen 44th Annual Health Care Conference. The event will take place on March 5, 2024, at 10:30 A.M. Eastern Time in Boston, MA. The live webcast will be accessible on the Ardelyx website, with a replay available for 30 days post-event.
Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Susan Rodriguez, chief commercial officer of Ardelyx, will participate in a Cardiorenal panel discussion at the Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 at 10:30 A.M. Eastern Time in Boston, MA.

To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations. A replay of the panel presentation will be available on the Ardelyx website for 30 days following the event.

About Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor) as well as early-stage pipeline candidates. Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com

 


FAQ

When will Susan Rodriguez participate in a Cardiorenal panel discussion?

Susan Rodriguez will participate in a Cardiorenal panel discussion on March 5, 2024, at 10:30 A.M. Eastern Time.

Where will the Cardiorenal panel discussion take place?

The Cardiorenal panel discussion will take place in Boston, MA.

How can I access the live webcast of the panel presentation?

You can access the live webcast of the panel presentation on the Ardelyx website at https://ir.ardelyx.com/events-and-presentations.

For how long will the replay of the panel presentation be available?

The replay of the panel presentation will be available on the Ardelyx website for 30 days following the event.

Ardelyx, Inc.

NASDAQ:ARDX

ARDX Rankings

ARDX Latest News

ARDX Stock Data

1.30B
231.98M
1.86%
62.06%
9.97%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
FREMONT